BMPR2 and pulmonary arterial hypertension: As a consequence, PAH patients who carry the BMPR2 mutation may have a reduced stability of pulmonary or bronchial vessels and may therefore be at an increased risk of rupture of blood vessels and subsequent hemoptysis.